Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease:... von Driessen, M T, Whalen, J, Seewoodharry Buguth, B, Vallejo-Aparicio, L A, Naya, I P, Asukai, Y, Alcázar-Navarrete, B, Miravitlles, M, García-Río, F, Risebrough, N A

Volltext

Correction to: Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulm... von Driessen, M T, Whalen, J, Buguth, B Seewoodharry, Vallejo-Aparicio, L A, Naya, I P, Asukai, Y, Alcázar-Navarrete, B, Miravitlles, M, García-Río, F, Risebrough, N A

Volltext

AB0420 Satisfaction and Unmet Need among Systemic Lupus Erythematosus (SLE) Patients Taking Standard of Care Medications (SOC) in A Real World Setting von Ramachandran, S., Pascoe, K., Hoskin, B., Lobosco, S., Bell, D., Pobiner, B., Asukai, Y.

Volltext

Cost-Effectiveness of Ipilimumab in Previously Untreated Patients for Advanced Melanoma in Sweden von Barzey, V, Asukai, Y, Gueron, B, Holmberg, C, Kotapati, S

Volltext

EE317 Examining ICER's Inclusion of Novel Value Factors: Do They Move the Needle on Value Appraisals? von Westrich, K., Buelt, L., Asukai, Y.

Volltext

Cost-effectiveness of rivaroxaban for the prevention of stroke in patients with non-valvular atrial fibrillation – a multinational study von Asukai, Y, Maniadakis, N, Carcedo, D, Lukac, M, Evers, T

Volltext

Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (COPD): Cross-Model Comparison of Hypothetical Treatment Scenarios von Hoogendoorn, M, Feenstra, T, Asukai, Y, Borg, S, Hansen, R.N, Jansson, S.A, Samyshkin, Y, Wacker, M, Briggs, A, Lloyd, A, Sullivan, S.D, Rutten-van Mölken, MP

Volltext

PCV51 Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Adult Patients With Non-Valvular Atrial Fibrillation with One or More Risk Factors – A... von Asukai, Y, Duran, A, Lloyd, A, McLeod, E.J, Evers, T, Broughton, J

Volltext

PCV49 Economic Evaluation of Rivaroxaban in Stroke Prevention Among Patients With Atrial Fibrillation in Greece von Kourlaba, G, Maniadakis, N, Andrikopoulos, G, Vardas, P, Llyod, A, Asukai, Y, Evers, T

Volltext

EE541 Cost-Effectiveness, Health-State Utility Values (HSUVs) and Cost and Resource Use (CRU) Associated with Patients with Higher-Risk Myelodysplastic Syndrome (HR-MDS): An Econom... von Papadakis-Sali, A., Bobrowska, A., Shaw, S., Sabate Estrella, E.J., Asukai, Y., Radford, M.

Volltext

CO25 A Systematic Literature Review (SLR) of the Clinical Efficacy and Safety Evidence Associated with Treatment of Patients with Higher-Risk Myelodysplastic Syndrome (HR-MDS) von Papadakis-Sali, A., Bobrowska, A., Shaw, S., Radford, M., Sabate Estrella, E.J., Asukai, Y.

Volltext

PIT3 Pharmacoeconomic Benefits of over-the-Counter Topical Diclofenac in the Treatment of Mild-to-Moderate ACUTE PAIN or Injury in Sweden von Asukai, Y., Klein, T., Smolen, L., Rios Martinez, S.

Volltext

PCV73 Prevention of Stroke in Patients With Atrial Fibrillation: Cost-Utility Analysis of Rivaroxaban Versus Warfarin in Slovakia von Psenkova, M, Lukac, M, Mackovicova, S, Stachova, M, Bielik, J, Pietsch, G.A, Asukai, Y, Lloyd, A, Evers, T

Volltext

EE348 The Cost-Effectiveness of Belimumab for the Treatment of Patients With Systemic Lupus Erythematosus (SLE) in China von He, X, Lloyd, E, Asukai, Y, Chauhan, D, Tang, Z, Treur, M

Volltext

PMS3 Calibration of a Cost-Effectiveness MODEL for Systemic LUPUS Erythematosus Using NEWLY Observed LONG-TERM Organ Damage DATA von Asukai, Y., Gait, C., Treur, M.

Volltext

PIT7 Pharmacoeconomic Benefits of over-the-Counter Topical Diclofenac in the Treatment of Mild-to-Moderate ACUTE PAIN or Injury and Short-TERM PAIN Associated with Chronic Conditio... von Asukai, Y., Deutsch, D., Klein, T., Smolen, L., Rios Martinez, S.

Volltext

MO2 Extrapolation in Oncology Modelling: Novel Methods for Novel Compounds von Annemans, L, Asukai, Y, Barzey, V, Kotapati, S, Lees, M, Van Baardewijk, M, Wang, Q, Batty, A.J, Fisher, D

Volltext

P377Zero-fluoroscopy ablation with ultrasound-guided sheath insertion von Kawakami, T, Saitoh, N, Asukai, Y, Wada, S, Sasaki, H, Takahashi, H, Hatori, K, Itou, N, Fukunaga, H, Toubaru, T

Volltext

P84 Utility Values For COPD Patients Based on the EQ-5D Questionnaire from Three Indacaterol Phase III Studies von Asukai, Y, Baldwin, M, Mungapen, L

Volltext

Belimumab for the Treatment of Adults Living with Active Systemic Lupus Erythematosus: A Cost-Effectiveness Analysis in Canada von Mursleen, S, Gahn, JC, Klein, RW, Asukai, Y

Volltext